Blockchain

SoMon Becomes Fastest-Growing Web3 Social App with 300,000 Transactions in Two Weeks

Hong Kong, Hong Kong, July 21st, 2024, Chainwire

 

SoMon, a decentralized Web3 forum with a vision to create a space for user-owned content and connections, recently launched its app on Base and has already gained more than 300,000 on-chain transactions in 14 days since its launch, making it the most active and fastest-growing social app in the Web3 space.

SoMon, short for Social Monster, allows users to monetize and create communities (Tribes) around their favorite topics, passions, creators, and fandoms. It is the first app built on OpenSocial Protocol, a composable infrastructure layer for building social applications, and also the first Web3 social app that is truly gasless, allowing it to lower the barrier of entry and onboard users beyond the crypto community.

Having launched its mobile app on 19 June 2024, around a month ago, it has garnered over 30,000 on-chain registrations in just two weeks. Today, the community is growing rapidly, with over 2 million social engagements among 300+ different Tribes (communities) and its 80,000+ users.

“Crypto is all about community, but instead of creating communities for users, we want communities to be built by users. SoMon is a user-curated space where people are able to connect with one another while taking charge and reaping the benefits of their own social achievements at the same time,” said Sean Tao, CEO & Co-Founder of SoMon.

SoMon users started minting their own Tribes using various tools and fragmented ownership powered by NFT technology after the new feature was released on 17 July 2024. Users create content, and the platform is monetized through a tool called ‘Megaphone’, allowing users to pay for promotional visibility, with the revenue being redistributed to Tribe owners and stakeholders.

SoMon is currently in its first season, ending on 31 July 2024. In this season, users compete to gain points through interactions and earn badges by climbing to different leagues. At the end of the season, SoMon will officially launch its community token, $OwO, which will be airdropped to the community at the end of the first season, with the first airdrop releasing 3% of its total supply this 1 August 2024, and 1% of its total supply for the subsequent seasons.

During upcoming seasons, SoMon is focused on activating the community economy via Tribe Summer campaign for users to create and engage with their bot-free community.

About SoMon

Social Monster (SoMon) is an open topic-based Web3 social app forum powered by OpenSocial Protocol. It serves as a space where users can create vibrant and engaging communities (Tribes) centered around their passions and fandoms. SoMon ensures that Tribes, content, and social connections are wholly owned by users.

 

Contact

Public Relations Manager
Kelvin Yeo Jun Hao
Everest Ventures Group
[email protected]

PostAd_coinrule_banner728x90

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Keiretsu Forum Announces Dr. Martin Gershon as Keynote Speaker for 2024 Investor Capital Expo

2024-10-02T11:08:00Z

PHILADELPHIA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Keiretsu Forum, the world's largest and most active accredited angel investor network, is proud to announce that Dr. Martin Gershon, a prominent leader in healthcare innovation and venture capital, will deliver the keynote address at the 2024 Investor Capital Expo. This signature event in early-stage investment community will be held on October 31, 2024, at Convene City View in Philadelphia.

Dr. Gershon, Managing Partner and Chief Investment Officer of Endeavor Venture Funds and Endeavor Venture Studio, brings over two decades of experience in life sciences and healthcare startups. His leadership at Endeavor has resulted in over 100 investments and 24 successful exits, solidifying his reputation as a strategic force in healthcare investment. Under his guidance, Endeavor Venture Funds has become synonymous with cutting-edge innovation, most recently, in artificial intelligence (AI)-powered drug discovery.

Recognized as a "Top Voice" in Venture Capital and Entrepreneurship by LinkedIn and named a Top 100 Healthcare Industry Leader by Standard & Poor’s, Dr. Gershon is a sought-after advisor and speaker. His keynote, titled "Pioneering Healthcare Innovation: Investment Strategies in AI Drug Discovery," will delve into the transformative impact of AI on the drug development process. His address will focus on:

  • Investment Opportunities: Exploring high-growth potential in AI-driven drug discovery.
  • Strategic Insights: Understanding how AI is accelerating the development of novel therapeutics.
  • Future Trends: Highlighting upcoming innovations that will shape the life sciences and healthcare sectors.

Keiretsu Forum: A Global Leader in Early-Stage Innovation

Keiretsu Forum continues to be a global leader in early-stage innovation, offering unparalleled access to groundbreaking companies across industries. The Investor Capital Expo serves as the premier gathering for angel investors, venture capitalists, family offices, and entrepreneurs, spotlighting companies that have undergone Keiretsu Forum's rigorous due diligence process. The event provides an invaluable platform for investors to engage with high-potential startups, network with peers, and gain insights from leading industry experts.

Keiretsu Forum has a relationship with Endeavor and Dr Gershon that has at its core aligned vision and lays the solid platform for access to a larger number of remarkable Founder Entrepreneurs and strategic partnerships with the Endeavor investor ecosystem for follow on rounds and sustained growth.

"Dr. Gershon's expertise in healthcare and AI makes him an ideal keynote speaker for this year’s Expo," said Howard Lubert, Regional President of Keiretsu Forum. "His contributions to the commercialization of life-saving technologies and his leadership in AI innovation exemplify the type of visionary thinking that drives the success of early-stage ventures."

Event Details

  • Date: October 31, 2024
  • Time: 8:00 AM – 6:00 PM EDT
  • Location: Convene City View, 30 S 17th St, Philadelphia, PA

Accredited angel investors are encouraged to register for this exclusive event, where they can engage with the next wave of industry disruptors and gain key insights from one of healthcare’s leading innovators.

About Keiretsu Forum :

Keiretsu Forum is the world’s largest private equity angel investment network with 2000+ accredited investors in 35 North American and 23 International chapters, who have invested more than $1B in early-stage companies in the last 23 years.

The Keiretsu Forum portfolio features Entrepreneurs and Companies from Technology-(Internet, Software, Cyber Security, SaaS, Mobile Systems, IoT, etc.), Life Sciences-(Pharma, Medical Devices, Health IT, etc.), FinServ/FinTech, Consumer Products, Clean-Green Energy, Consumer Products, & more!

About Dr. Martin Gershon

Dr. Gershon's career has been marked by his pioneering efforts in healthcare and life sciences innovation. His role at Endeavor Venture Funds connects emerging companies with Fortune 500 partnerships, offering strategic growth solutions and regulatory expertise. Dr. Gershon has advised numerous organizations, including the White House Moonshot CancerX Accelerator, Goldman Sachs, and Bain Capital.

Dr. Gershon’s academic credentials are equally impressive, with advanced training in neuroscience, oncology, and immunology from Harvard, McGill, and Columbia. He has also served as an FDA attorney and has been honored as a Google Scholar in Entrepreneurship.

For media inquiries, please contact:

Cindi Sutera
AMS Communications
[email protected]
610-613-2773


GlobeNewsWire News

Recent Comments